Caraco Pharmaceutical Laboratories, Ltd. engages in the development, manufacture, and marketing of generic, prescription, and over-the-counter pharmaceuticals. The company offers Allopurinol, an anti-gout; Amifostine for injection used as oncology adjunct; Amlodipine Besylate tablets, Atenolol, Carvedilol, and Metoprolol Tartrate, which are antihypertensive drug/beta blockers; Baclofen and Tizanidine, which are skeletal muscle relaxants; Carbamazepine, Gabapentin, Phenytoin Sodium extended release capsules, Zonisamide, and Oxcarbazepine, which are anticonvulsants; Carbidopa and Levodopa ER for the treatment of Parkinson disease; and Carisoprodol, a muscle relaxants. It also provides Cetirizine HCl chewable tablets, which are antiallergic drugs; Choline Magnesium Trisalicylate, Flurbiprofen, Meloxicam, Salsalate, and Oxaprozin, which are used as nonsteroidal anti-inflammatory agents; Citalopram HBr, Mirtazapine, and Paroxetine, which are antidepressants; Clonazepam for the treatment of seizure and panic disorders; Clozapine, an antipsychotic; Digoxin, a cardiac drug; Glipizide, Glipizide/Metformin HCl tablets, Metformin HCl, and Metformin HCl extended release, which are antidiabetics; Hydrochlorothiazide, an antihypertensive product; and Meperidine HCl, which are narcotic and analgesic drugs. In addition, the company offers Midrin, a vascular and migraine headache suppressant; Nimodipine, a calcium channel blocker; Octreotide Acetate injection, and Ondansetron injection, ODT, and tablets that are used as oncology adjuncts; Pantoprazole, an anti-ulcerants; Paromomycin Sulfate, an antibiotic; Ticlopidine, a platelet aggregation inhibitor; Torsemide, a diuretic; Zolpidem, sedatives and hypnotics; and Tramadol HCl tablets, and Tramadol HCl and Acetaminophen tablets, which are opiate agonist/analgesic. The company was founded in 1984 and is based in Detroit, Michigan. Caraco Pharmaceutical Laboratories, Ltd. is a subsidiary of Sun Pharmaceutical Industries Limited.